Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hugo F Fernandez

Showing results (1-10 of 60) with videos related to

Pageof 6
Sort By:
Clinical Lymphoma, Myeloma & Leukemia|August 23, 2015
Allogeneic Transplantation for Unfavorable-Risk Acute Myeloid LeukemiaHugo F Fernandez
Current Hematologic Malignancy Reports|August 1, 2016
What Is the Optimal Induction Therapy for Younger Fit Patients With AML?Hugo F Fernandez
Hematology. American Society of Hematology. Education Program|January 18, 2011
New trends in the standard of care for initial therapy of acute myeloid leukemiaHugo F Fernandez
Current Opinion in Hematology|January 21, 2010
Induction therapy in acute myeloid leukemia: intensifying and targeting the approachHugo F Fernandez, Jacob M Rowe
Cancer Control : Journal of the Moffitt Cancer Center|April 2, 2009
Tyrosine kinase inhibitors and allogeneic hematopoietic cell transplantation for chronic myeloid leukemia: targeting both therapeutic modalitiesHugo F Fernandez, Mohamed A Kharfan-Dabaja
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 30, 2008
Allogeneic hematopoietic cell transplantation for adult Philadelphia-positive acute lymphoblastic leukemia in the era of tyrosine kinase inhibitorsYasser R Abou Mourad, Hugo F Fernandez, Mohamed A Kharfan-Dabaja
Hematology (Amsterdam, Netherlands)|February 18, 2004
Thalidomide effects in the post-transplantation setting in patients with multiple myelomaEdgardo S Santos, Mark Goodman, John J Byrnes, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 11, 2002
Evaluation of safety and pharmacokinetics of administering intravenous busulfan in a twice-daily or daily schedule to patients with advanced hematologic malignant disease undergoing stem cell transplantationHugo F Fernandez, Hai T Tran, Federico Albrecht, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 19, 2007
Hematopoietic cell transplantation in acute promyelocytic leukemia: a comprehensive reviewMohamed A Kharfan-Dabaja, Yasser R Abou Mourad, Hugo F Fernandez, et al.
American Journal of Hematology|June 8, 2012
Retrospective comparison of filgrastim plus plerixafor to other regimens for remobilization after primary mobilization failure: clinical and economic outcomesJanelle B Perkins, Jamie F Shapiro, Ryan N Bookout, et al.
Pageof 6

Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
Clinical Lymphoma, Myeloma & Leukemia|August 23, 2015
Allogeneic Transplantation for Unfavorable-Risk Acute Myeloid LeukemiaHugo F Fernandez
Current Hematologic Malignancy Reports|August 1, 2016
What Is the Optimal Induction Therapy for Younger Fit Patients With AML?Hugo F Fernandez
Hematology. American Society of Hematology. Education Program|January 18, 2011
New trends in the standard of care for initial therapy of acute myeloid leukemiaHugo F Fernandez
Current Opinion in Hematology|January 21, 2010
Induction therapy in acute myeloid leukemia: intensifying and targeting the approachHugo F Fernandez, Jacob M Rowe
Cancer Control : Journal of the Moffitt Cancer Center|April 2, 2009
Tyrosine kinase inhibitors and allogeneic hematopoietic cell transplantation for chronic myeloid leukemia: targeting both therapeutic modalitiesHugo F Fernandez, Mohamed A Kharfan-Dabaja
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 30, 2008
Allogeneic hematopoietic cell transplantation for adult Philadelphia-positive acute lymphoblastic leukemia in the era of tyrosine kinase inhibitorsYasser R Abou Mourad, Hugo F Fernandez, Mohamed A Kharfan-Dabaja
Hematology (Amsterdam, Netherlands)|February 18, 2004
Thalidomide effects in the post-transplantation setting in patients with multiple myelomaEdgardo S Santos, Mark Goodman, John J Byrnes, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 11, 2002
Evaluation of safety and pharmacokinetics of administering intravenous busulfan in a twice-daily or daily schedule to patients with advanced hematologic malignant disease undergoing stem cell transplantationHugo F Fernandez, Hai T Tran, Federico Albrecht, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 19, 2007
Hematopoietic cell transplantation in acute promyelocytic leukemia: a comprehensive reviewMohamed A Kharfan-Dabaja, Yasser R Abou Mourad, Hugo F Fernandez, et al.
American Journal of Hematology|June 8, 2012
Retrospective comparison of filgrastim plus plerixafor to other regimens for remobilization after primary mobilization failure: clinical and economic outcomesJanelle B Perkins, Jamie F Shapiro, Ryan N Bookout, et al.
Pageof 6